// App-Quantinova.ai

394 : Genome-Wide Association Study Identifies Novel Risk Variants in BCL11A-PAPOLG for TCF3-PBX1 Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Shawn Lee

Principal Investigators

  • Wentao Yang

  • Jonathan Diedrich

  • Elizabeth A. Raetz

  • Wenjian Yang

  • Qian Dong

  • Meenakshi Devidas

  • Deqing Pei

  • Allen Eng Juh Yeoh

  • Cheng Cheng

  • Ching-Hon Pui

  • William E. Evans

  • Charles G Mullighan

  • Stephen P Hunger

  • Daniel Savic

  • Mary V. Relling

  • Mignon L. Loh

  • Jun J. Yang

Medical Centers

  • Department of Pharmaceutical Sciences, St Jude Children's Research Hospital, Memphis, TN

  • Children's Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, TN

  • New York University Medical Center, New York City, NY

  • Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

  • Centre for Translational Research in Acute Leukaemia, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  • Department of Oncology, Member, St Jude Faculty, Chair, Oncology Department, Coleader, Hematological Malignancies Program, Director, China Region, St Jude Global, American Cancer Society Professor, Fahad Nassar Al-Rashid Chair of Leukemia Research, St Jude Children’s Research H, Memphis, TN

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

  • Department of Pediatrics, Division of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

  • Department of Pediatrics, Division of Hematology-Oncology, University of California, San Francisco and Benioff Children's Hospital, San Francisco, CA

Locations

  • United States

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A